Synthetic organic

Product description：GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.

Product description：GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.

Product description：GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.

Product description：GSK650394 is a serum- and glucocorticoid-regulated kinase-1 inhibitor.

A compound that inhibits cell proliferation in cancer cell lines. It does this by being an irreversible mechanism-based inhibitor of LSD1. LSD1 is part of the family-dependant amine oxidases that include PAOs and MAOs.

A compound that inhibits cell proliferation in cancer cell lines. It does this by being an irreversible mechanism-based inhibitor of LSD1. LSD1 is part of the family-dependant amine oxidases that include PAOs and MAOs.

A compound that inhibits cell proliferation in cancer cell lines. It does this by being an irreversible mechanism-based inhibitor of LSD1. LSD1 is part of the family-dependant amine oxidases that include PAOs and MAOs.

GSK PERK inhibitor.

InformationGSK'963 GSK'963 is a chiral small-molecule inhibitor of RIP1 kinase (RIPK1) with an IC50 of 29 nM in FP binding assays. It is &gt:10 000-fold selective for RIP1 over 339 other kinases.TargetsRIP1 kinase (Cell-free assay) 29 nMIn

InformationGSK'963 GSK'963 is a chiral small-molecule inhibitor of RIP1 kinase (RIPK1) with an IC50 of 29 nM in FP binding assays. It is &gt:10 000-fold selective for RIP1 over 339 other kinases.TargetsRIP1 kinase (Cell-free assay) 29 nMIn

InformationGSK'963 GSK'963 is a chiral small-molecule inhibitor of RIP1 kinase (RIPK1) with an IC50 of 29 nM in FP binding assays. It is &gt:10 000-fold selective for RIP1 over 339 other kinases.TargetsRIP1 kinase (Cell-free assay) 29 nMIn

InformationGSK'963 GSK'963 is a chiral small-molecule inhibitor of RIP1 kinase (RIPK1) with an IC50 of 29 nM in FP binding assays. It is &gt:10 000-fold selective for RIP1 over 339 other kinases.TargetsRIP1 kinase (Cell-free assay) 29 nMIn